XML 42 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2014
Fair Value Measurements [Abstract]  
Schedule of assets measured at fair value on a recurring basis

We measure the following major security types at fair value on a recurring basis. The following summary breaks down the fair-value hierarchy that each security is valued with at September 30, 2014 and December 31, 2013 as follows (in thousands):

  
At September 30,
2014
  
Quoted Prices in
Active Markets
(Level 1)
  
Significant Other
Observable
Inputs
(Level 2)
  
Significant
Unobservable
Inputs
(Level 3)
 
Cash equivalents
 
$
44,551
  
$
44,551
  
$
  
$
 
Corporate debt securities (1)
  
353,848
   
   
353,848
   
 
Debt securities issued by U.S. government agencies (1)
  
106,397
   
   
106,397
   
 
Debt securities issued by the U.S. Treasury
  
9,040
   
9,040
   
   
 
Debt securities issued by states of the United States and political subdivisions of the states (1)
  
64,344
   
   
64,344
   
 
Investment in Regulus Therapeutics Inc.
  
47,426
   
47,426
   
   
 
Equity securities (2)
  
1,021
   
1,021
   
   
 
Total
 
$
626,627
  
$
102,038
  
$
524,589
  
$
 

  
At December 31,
2013
  
Quoted Prices in
Active Markets
(Level 1)
  
Significant Other
Observable
Inputs
(Level 2)
  
Significant
Unobservable
Inputs
(Level 3)
 
Cash equivalents
 
$
133,233
  
$
133,233
  
$
  
$
 
Corporate debt securities (1)
  
407,897
   
   
407,897
   
 
Debt securities issued by U.S. government agencies
  
64,432
   
   
64,432
   
 
Debt securities issued by the U.S. Treasury
  
15,328
   
15,328
   
   
 
Debt securities issued by states of the United States and political subdivisions of the states
  
22,255
   
   
22,255
   
 
Investment in Regulus Therapeutics Inc.
  
52,096
   
52,096
   
   
 
Equity securities (2)
  
1,276
   
1,276
   
   
 
Total
 
$
696,517
  
$
201,933
  
$
494,584
  
$
 

(1)Includes investments classified as cash equivalents on our condensed consolidated balance sheet.

(2)Included in other current assets on our condensed consolidated balance sheet.

Summary of investments measured at fair value on a recurring basis using significant unobservable inputs (Level 3)
The following is a summary of our investments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended September 30, 2014 (in thousands):
   
Beginning balance of Level 3 investments
 
$
-
 
   Total gain included in accumulated other comprehensive income (loss)
  
1,231
 
   Transfers out of Level 3 investments
  
(1,231
)
Ending balance of Level 3 investments
 
$
-